EP 3761966 A2 20210113 - PHARMACEUTICAL COMPOSITION COMPRISING ELTROMBOPAG OLAMINE, REDUCING SUGAR, AND POLYMERIC BINDER
Title (en)
PHARMACEUTICAL COMPOSITION COMPRISING ELTROMBOPAG OLAMINE, REDUCING SUGAR, AND POLYMERIC BINDER
Title (de)
PHARMAZEUTISCHE ZUSAMMENSETZUNG MIT ELTROMBOPAG OLAMIN, REDUZIERENDEM ZUCKER UND POLYMEREM BINDEMITTEL
Title (fr)
COMPOSITION PHARMACEUTIQUE COMPRENANT DE L'ELTROMBOPAG OLAMINE, UN SUCRE RÉDUCTEUR ET UN LIANT POLYMÈRE
Publication
Application
Priority
- IN 201811008417 A 20180307
- EP 18169614 A 20180426
- EP 2019055706 W 20190307
Abstract (en)
[origin: EP3409272A1] The present invention relates to a pharmaceutical tablet composition comprising eltrombopag olamine, one or more reducing sugars, and one or more polymeric binder agents, a production process therefore, a pharmaceutical tablet composition comprising eltrombopag olamine, one or more reducing sugars, and one or more polymeric binder agents obtainable by the production process, a use / method of use of the pharmaceutical tablet compositions in the treatment or prophylaxis of immune (idiopathic) thrombocytopenic purpura (ITP), thrombocytopenia and/or acquired severe aplastic anaemia (SAA).
IPC 8 full level
A61K 9/20 (2006.01); A61K 31/4152 (2006.01); A61P 7/02 (2006.01)
CPC (source: EP)
A61K 9/2018 (2013.01); A61K 9/2027 (2013.01); A61K 31/4152 (2013.01); A61P 7/02 (2017.12)
Citation (search report)
See references of WO 2019086725A2
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
EP 3409272 A1 20181205; EP 3409272 A9 20190116; EP 3409272 B1 20200624; AU 2019203327 A1 20201001; EP 3761966 A2 20210113; WO 2019086725 A2 20190509; WO 2019086725 A3 20190711
DOCDB simple family (application)
EP 18169614 A 20180426; AU 2019203327 A 20190307; EP 19708854 A 20190307; EP 2019055706 W 20190307